Shopping Cart
- Remove All
- Your shopping cart is currently empty
(S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent inhibitor of CDKs capable of crossing the blood-brain barrier. It exhibits neuroprotective effects and holds potential for use in stroke research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | (S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent inhibitor of CDKs capable of crossing the blood-brain barrier. It exhibits neuroprotective effects and holds potential for use in stroke research. |
Targets&IC50 | CDK7:≤1 μM, CDK1:≤1 μM, CDK2:≤1 μM, CDK5:≤1 μM, CDK9:≤1 μM |
In vivo | In an animal model study using 20-25 g, P60 male C57 b/6 mice, '(S)-Roscovitine' (25 mg/kg; i.p.; administered 15 minutes before and 1 hour after permanent middle cerebral artery occlusion [pMCAo]) demonstrated neuroprotective effects. The treatment resulted in a reduction of the total infarct volume in this model. |
Alias | (S)-Seliciclib, (S)-CYC202 |
Molecular Weight | 354.45 |
Formula | C19H26N6O |
Cas No. | 186692-45-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.